Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nanocurcumin for treatment of Helicobacter pylori infection
IRCT20230131057297N1Phase 3Completed
- Sponsor
- Vice Chancellor for Research, Birjand University of Medical Sciences
- Start
- Jun 2023
- Modality
- Small Molecules, Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3 trial of nanocurcumin in Helicobacter pylori infection, sponsored by Vice Chancellor for Research, Birjand University of Medical Sciences. Started Jun 2023; status: completed.
02
Drugs
nanocurcumin
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on IRCT20230131057297N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230131057297N1.